A new computational approach that allows the identification of molecular alterations associated with prognosis and resistance to therapy of different types of cancer was developed by the research group led by Nuno Barbosa Morais at Instituto de Medicina Molecular João Lobo Antunes (iMM; Portugal). It has been published in Nucleic Acids Research.